TrialJournal of the National Cancer Institute2021

Cyclophosphamide-Free Adjuvant Chemotherapy for Ovarian Protection in Young Women With Breast Cancer: A Randomized Phase 3 Trial.

Ke-Da Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.